![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bd6020contents.gif)
Acta Cryst. (2006). E62, o288-o289 [ doi:10.1107/S1600536805040547 ]
Abstract: The title compound, C11H14Br2N2O3, was synthesized by condensation of methyl l-2-amino-3-methylbutanoate with 4,5-dibromo-2-trichloroacetylpyrrole at room temperature. In the crystal structure, intermolecular N-H
O hydrogen-bonding interactions link the molecules, forming extended chains parallel to [010]. Bioactivity tests show that the title compound inhibits bacteria and also exhibits cytotoxicity.
Online 21 December 2005
Copyright © International Union of Crystallography
IUCr Webmaster